Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
GHK-Cu is NOT FDA-approved for hair loss, and it is currently classified as a cosmetic peptide
Concurrent treatment: Physical therapy and appropriate activity modification support peptide effects
Direct stimulation of -cell D2R and D3R with dopamine (DA) or D2R/D3R agonists inhibits glucose-stimulated insulin secretion (GSIS) in both human and mouse pancreatic islets 6,7,8,10 , suggesting that -cell D2R/D3R signaling is an important regulator of GSIS 5,6,8,9
BMJ , 349, g5226
For those willing to accept this level of uncertainty, the risk-benefit calculation may still favor trying BPC-157, especially given its favorable safety profile and the limited options for chronic back pain sufferers
